Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Protease Inhibitor Treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100227313A1
SERIAL NO

12527861

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to methods for determining altered susceptibility of HIV-I viruses to protease inhibitors (PIs) based on the viral genotypes. The methods generally comprise detecting, in a gene encoding protease and/or gag of the HIV-I, the presence of mutations correlated with altered susceptibility to amprenavir and/or darunavir.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LABORATORY CORPORATION OF AMERICA HOLDINGS358 SOUTH MAIN STREET BURLINGTON NC 27215

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chappey, Colombe San Francisco, US 10 40
Parkin, Neil T Belmont, US 41 333
Stawiski, Eric San Francisco, US 4 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation